Allergy & Immunology

The trial included 135 adults, randomly assigned to receive either inebilizumab or a placebo for a 52-week treatment period.

In the trial, patients received either IL-2 (1 MUI/day) or a placebo for 5 days, followed by weekly doses for 4 weeks.

The study aims to customise CIC profiles for patients, providing insights into which stages of the cycle are most relevant for tailored cancer therapies and diagnostics.

he study aimed to evaluate how gestational age at the time of vaccination and the time elapsed until delivery impacted antibody levels in the newborn.

Groundbreaking research from Emory University has revealed that autoantibodies found in the nasal cavity may provide a critical defence against severe COVID-19 symptoms.

A recent review reveals significant racial and ethnic disparities in FOIT clinical trials.

A recent systematic review and meta-analysis highlights concerns about antibiotic resistance in Staphylococcus aureus strains found in individuals with atopic dermatitis.

A case study from ACAAI highlights the health risks of incense burning, particularly affecting respiratory health.